Ortin Global, a company in the Pharmaceuticals industry, reported revenue of ₹0.04 crore and a net loss of ₹0.27 crore for the September 2026 quarter.
Ortin Global (NSE: ORTINGLOBE) closed at ₹12.37 on 20 Nov 2026, up 3.1% over the past year. Its market capitalisation is ₹10 crore.
Incorporated in 1986, Ortin Laboratories Ltd manufactures pharmaceutical formulations.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.